PharmaMar receives positive opinion from EMA (COMP) for orphan drug designation of Zepsyre® (lurbinectedin) for small-cell lung cancer 글 내용 전체보기
MGB Biopharma – FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3, a Novel, Potent Bactericidal Antibiotic Targeting Clostridium difficile-Associated 글 내용 전체보기
New Combined Diagnostic and Antimicrobial Susceptibility Test Enables Resistance-Guided Therapy for Gonorrhoea 글 내용 전체보기
Increasing Number of Post-surgical Ostomy Procedures Expected to Boost Demand for Ostomy Drainage Bags 글 내용 전체보기
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering 글 내용 전체보기
MassBio’s Annual Policy Leadership Breakfast Addresses Efforts to Lower Prescription Drug Costs 글 내용 전체보기
